78 results
Page 2 of 4
6-K
EX-99.1
pv2ys0baqu8du
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
4jd14zk8vi4tc40kc8li
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K/A
EX-99.1
6op61xxkq 1z3qsdum
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.4
08jwvtas
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
y81zbk6hpb2g1j0emm
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-5.2
ca3tu
30 Sep 22
Current report (foreign)
4:24pm
6-K
EX-5.1
evcfn7dbfhfr4w
30 Sep 22
Current report (foreign)
4:24pm
424B7
vfex mmg7s3463
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-5.1
vkce984234a 72bzvif
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
6-K
EX-99.1
x07k7dy1lpt
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
7kuxnihtxy9yahz4
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
EX-99.2
l4qxq5f62 08
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.1
o154sx
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
gzluftdn4hc5b
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.3
13y2oxnk7nme3n
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
c6vblzgrv n64wqs7u
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
esx8ax dy
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
h77j5om0k05
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
iwkr67 r30b32twp1mv
6 Jun 22
Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic
4:21pm
S-8
EX-5.1
1s2ipi 1bea
17 May 22
Registration of securities for employees
7:01am